183 related articles for article (PubMed ID: 32559766)
21. Fibrillary glomerulopathy secondary to light chain deposition disease in a patient with monoclonal gammopathy.
Sundaram S; Mainali R; Norfolk ER; Shaw JH; Zhang PL
Ann Clin Lab Sci; 2007; 37(4):370-4. PubMed ID: 18000296
[TBL] [Abstract][Full Text] [Related]
22. Biopsy-proven resolution of renal light-chain deposition disease after autologous stem cell transplantation.
Petrakis I; Stylianou K; Mavroeidi V; Vardaki E; Stratigis S; Stratakis S; Xylouri I; Perakis C; Petraki C; Nakopoulou L; Daphnis E
Nephrol Dial Transplant; 2010 Jun; 25(6):2020-3. PubMed ID: 20133281
[TBL] [Abstract][Full Text] [Related]
23. [Deposition of light chains in various organs; light chain deposition disease].
van Klaveren RJ; Holdrinet RS; Assmann KJ
Ned Tijdschr Geneeskd; 1989 May; 133(18):943-6. PubMed ID: 2498673
[TBL] [Abstract][Full Text] [Related]
24. A case of monoclonal immunoglobulin light- and heavy-chain deposition disease exhibiting atypical deposition with fibrillary structures, successfully treated with chemotherapy.
Nakatsuka A; Maeshima Y; Sarai A; Yanai H; Sugiyama H; Yamasaki Y; Makino H
Clin Nephrol; 2005 Sep; 64(3):221-7. PubMed ID: 16175947
[TBL] [Abstract][Full Text] [Related]
25. [Complete remission of nephrotic syndrome and improvement of renal function in a patient with light chain deposition disease following high dose chemotherapy with transplantation of autologous haematopoietic stem cells. A case study and review of literature].
Adam Z; Krejcí M; Pour L; Stepánková S; Cermáková Z; Voska L; Teplan V; Krivanová A; Hájek R; Mayer J
Vnitr Lek; 2009 Nov; 55(11):1089-96. PubMed ID: 20017442
[TBL] [Abstract][Full Text] [Related]
26. A case of isolated light chain deposition disease in the duodenum.
Kim HJ; Park E; Lee TJ; Do JH; Cha YJ; Lee SJ
J Korean Med Sci; 2012 Feb; 27(2):207-10. PubMed ID: 22323870
[TBL] [Abstract][Full Text] [Related]
27. Proliferative glomerulonephritis with discrete deposition of monoclonal immunoglobulin γ1 CH 2 heavy chain and κ light chain: a new variant of monoclonal immunoglobulin deposition disease.
Komatsuda A; Ohtani H; Sawada K; Joh K; Wakui H
Pathol Int; 2013 Jan; 63(1):63-7. PubMed ID: 23356227
[TBL] [Abstract][Full Text] [Related]
28. siRNA targeting the κ light chain constant region: preclinical testing of an approach to nonfibrillar and fibrillar light chain deposition diseases.
Ma X; Zhou P; Wong SW; Warner M; Chaulagain C; Comenzo RL
Gene Ther; 2016 Oct; 23(10):727-733. PubMed ID: 27383253
[TBL] [Abstract][Full Text] [Related]
29. Renal granular monoclonal light chain deposits: morphological aspects in 11 cases.
Noel LH; Droz D; Ganeval D; Grunfeld JP
Clin Nephrol; 1984 May; 21(5):263-9. PubMed ID: 6428790
[TBL] [Abstract][Full Text] [Related]
30. OCULAR MANIFESTATIONS OF MONOCLONAL IMMUNOGLOBULIN LIGHT CHAIN DEPOSITION DISEASE.
Dhrami-Gavazi E; Freund KB; Lee W; Cohen BZ; Seshan SV; Yannuzzi LA
Retin Cases Brief Rep; 2017 Fall; 11(4):310-315. PubMed ID: 27315323
[TBL] [Abstract][Full Text] [Related]
31. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
Bridoux F; Delbes S; Sirac C; Pourreau F; Puyade M; Desport E; Jaccard A; Fermand JP; Touchard G
Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
[TBL] [Abstract][Full Text] [Related]
32. Randall-type monoclonal immunoglobulin deposition disease: novel insights from a nationwide cohort study.
Joly F; Cohen C; Javaugue V; Bender S; Belmouaz M; Arnulf B; Knebelmann B; Nouvier M; Audard V; Provot F; Gnemmi V; Nochy D; Goujon JM; Jaccard A; Touchard G; Fermand JP; Sirac C; Bridoux F
Blood; 2019 Feb; 133(6):576-587. PubMed ID: 30578255
[TBL] [Abstract][Full Text] [Related]
33. Renal monoclonal immunoglobulin deposition disease: the disease spectrum.
Lin J; Markowitz GS; Valeri AM; Kambham N; Sherman WH; Appel GB; D'Agati VD
J Am Soc Nephrol; 2001 Jul; 12(7):1482-1492. PubMed ID: 11423577
[TBL] [Abstract][Full Text] [Related]
34. Light chain deposition disease masquerading as smoking-associated nodular glomerulosclerosis with deposits identified by electron microscopy only.
Alom MS; Grewal R; Passero FC; Goldman B; Choung HYG
CEN Case Rep; 2022 Nov; 11(4):448-452. PubMed ID: 35316527
[TBL] [Abstract][Full Text] [Related]
35. Kidney and liver involvement in monoclonal light chain disorders.
Pozzi C; Locatelli F
Semin Nephrol; 2002 Jul; 22(4):319-30. PubMed ID: 12118397
[TBL] [Abstract][Full Text] [Related]
36. Nodular glomerulopathy associated with nonamyloidotic kappa light chain deposits and excess immunoglobulin light chain synthesis.
Gallo GR; Feiner HD; Katz LA; Feldman GM; Correa EB; Chuba JV; Buxbaum JN
Am J Pathol; 1980 Jun; 99(3):621-44. PubMed ID: 6770693
[TBL] [Abstract][Full Text] [Related]
37. Renal manifestations of plasma cell dyscrasias: an appraisal from the patients' bedside to the research laboratory.
Herrera GA
Ann Diagn Pathol; 2000 Jun; 4(3):174-200. PubMed ID: 10919389
[TBL] [Abstract][Full Text] [Related]
38. Can We Cure Light Chain Deposition Disease of the Kidneys?-A Review and Case Report of a Patient Treated With a Triple Transplant Approach.
Sivaraj D; Green MM; Ciftci AM; Zahid MF; Johns AA; Ross M; Gasparetto C
Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):e95-e100. PubMed ID: 27101986
[No Abstract] [Full Text] [Related]
39. AL-amyloidosis and light-chain deposition disease light chains induce divergent phenotypic transformations of human mesangial cells.
Keeling J; Teng J; Herrera GA
Lab Invest; 2004 Oct; 84(10):1322-38. PubMed ID: 15286662
[TBL] [Abstract][Full Text] [Related]
40. Long-term outcome of renal transplantation in light-chain deposition disease.
Leung N; Lager DJ; Gertz MA; Wilson K; Kanakiriya S; Fervenza FC
Am J Kidney Dis; 2004 Jan; 43(1):147-53. PubMed ID: 14712438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
